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Opioid Agonist Treatment (OAT) programmes are regarded as a gold standard
treatment for  people living with Opioid Use Disorders (OUDs). However, OAT
programmes are often unavailable or poorly implemented in prisons, in spite of the
large numbers of people living with OUDs and the high risk of HIV transmission in
prison settings. Unusually, this systematic review synthesizes qualitative evidence
relating to barriers to, and facilitators of, the implementation of OAT programmes in
prisons in high- and low/middle-income countries (LMICs) to provide more nuanced,
contextualised understandings of how prison stakeholders perceive and/or experience
OAT programmes within different prison settings.
Methods:
We systematically reviewed six electronic databases for studies published between
January 2005 and December 2019 involving prison stakeholders: policy-makers,
governors, healthcare staff, prison officers, and prisoners. The search identified 8091
studies, of which only 16 incorporated qualitative methods (including qualitative
elements of mixed methods) and met our quality criteria. Four of these studies were
conducted in LMICs (Kyrgyzstan, Iran (2) and Indonesia). 
Results:
Findings were organized under three broad themes: (1) perceived benefits of OAT
programmes; (2) barriers to the implementation and development of OAT programmes;
and (3) treatment processes. 
Discussion: 
A lack of a clear understanding of the roles of OAT programmes and doubts regarding
their effectiveness for people living with OUDs in prisons are critical barriers to prisoner
participation in both high-and LMIC countries. Prison systems, particularly in LMICs,
often lack the resources to mitigate problems with implementation. This review
highlights an urgent need to develop further qualitative studies into prison OAT
programmes, employing varied methods to explore such contexts in greater depth and
minimize the impact of harms relating to OUDs in prisons.
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A systematic review and meta-analysis of drug use in prisons in mostly higher income 
countries reported that the prevalence of opioid use disorders (OUDs) among prisoners 
on entry into prison was 61% (for men) and 69% (for women) respectively (Fazel et al. 
2017). This represents a  rise in prevalence since the 2000s, when it was estimated to 
be between 48% for men and 60% for women prisoners (Fazel et al. 2006). 
 
Other systematic reviews have indicated that one third of prisoners use illicit drugs while 
incarcerated (Mundt et al., 2018), with heroin the most commonly used drug (70%) 
(Strang et al., 2005). Injecting heroin use poses a significant risk of transmission of blood-
borne viral (BBV) infections, such as hepatitis B and C and human immunodeficiency 
viruses (HIV), a risk that increases in prison where needle and syringe exchange 
programmes are not available (Azbel et al., 2018, Altice et al., 2016, Jürgens et al., 2011). 
For example, 56% of HIV-infected prisoners in Culbert et al.’s (2015) study in two 
Indonesian prisons reported having injected heroin while in prison. Furthermore, 94.5% 
of this same group confirmed having shared injecting equipment, with 80% having done 
so with more than ten other prisoners.  
 
Opioid agonist treatment (OAT) programmes, involving the regular oral administration of 
long-acting opioid agonist drugs, such as methadone and buprenorphine, are regarded 
as an effective, evidence-based intervention for people with opioid  dependence and for 
the prevention of HIV transmission among injecting drug users (IDUs) (WHO, UNAIDS 
and UNODC 2004). Quantitative reviews have indicated that OAT is effective in prison 
contexts. Notably, in New South Wales (Australia) Larney et al. (2010) found reductions 
of between 62% and 91% in illicit opioid use, between 47% and 73% in needle and 
syringe sharing, and between 55% and 75% in injecting drug use.  Post-release OAT 
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programmes have also been shown to reduce the likelihood of relapse back to the use 
of black market opiates and therefore the risk of re-incarceration (Malta et al. 2019).  
 
The extant evidence therefore suggests that access to OAT programmes in prisons 
should be a public health priority, as recommended by the WHO since 1993. However, 
this recommendation has been ignored in many prison systems (Chandler et al., 2009) 
out of philosophical preferences for drug-free treatments, concerns relating to prison 
security, and widespread misconceptions and stigma associated with OAT programmes 
(Friedmann et al., 2012, McKenzie et al., 2009, Mitchell et al., 2009). As a result, OAT 
programmes remain unavailable in many prison settings (Sander et al., 2016).  
As discussed, quantitative systematic reviews and meta-analyses have clearly 
demonstrated the effectiveness of prison OAT programmes. Drawing on a 
positivist research paradigm, these studies have investigated large samples, and 
used statistical tools to generate generalizable results.  However, to build on this 
work and better understand the challenges of implementing and encouraging 
participation in OAT programmes, further exploration of how prison staff and 
prisoners perceive and/or experience these programmes within different prison 
settings is needed.  
Therefore, in contrast to the great majority of systematic reviews, this review 
focuses on qualitative studies. Interpretivist studies allow for more nuanced and 
in-depth understandings of the specificities of local cultural, religious and 
economic contexts and of the varied meanings and purposes attached to OAT 
programmes in different settings. Such contextualised knowledge is essential for 
effective policy-making and implementation (Guba and Lincoln, 1994) but is often 
3 
 
lost in quantitative studies through their use of the broader concepts required for 
quantification. Alongside Grella et al. (2020), this review is also one of the few 
such studies to examine barriers to and facilitators of OAT programmes in 
prisons from the perspective of both prison staff (policy-makers, prison officers 
and health care staff) and prisoners. The focus in this review on implications for 
prison systems in lower middle income countries (LMICs), and the involvement 
of researchers with experience of working in an LMIC prison system, should also 
be noted and reflect the initial purpose of this systematic review to support the 
development of a qualitative research project on the implementation of OAT 
programmes in Indonesia, where there are concentrated epidemics among 
people who inject drugs (UNAIDS DATA 2019), many of whom are incarcerated 
(Altice et al. 2016; Morineau et al. 2012). 
Research questions  
The SPICE framework was employed to help formulate research questions 
appropriate to a qualitative review. This framework is commonly used in public 
health research (Booth, 2006) as it helps both to clarify the nature of the problem 
and to provide a robust supportive framework for a systematic literature search, 







Table 1. SPICE anatomy of OAT programmes in prisons 
S    Setting  Prison  
P    Perspectives  Different groups (policy makers, prison healthcare staff, 
prison officers, and prisoners)  
I    Intervention  OAT programmes 
C    Comparison  Higher and low-middle income countries (LMICs) 
E    Evaluation  Perceptions and experiences of barriers and facilitators  
The research questions developed for this review were:  
1) What are the experiences of stakeholders, including policy makers, healthcare 
staff, prison officers and prisoners, in implementing, delivering or participating in 
OAT programmes?  
2) What do stakeholders see as the barriers to and facilitators of existing OAT 
programmes?  
3) From the perspective of stakeholders, what factors determine the successful 
implementation of OAT programmes in prisons? 
4) What are the implications of these results for the implementation of OAT 
programmes in prisons in Indonesia and other LMIC countries? 
Review design 
This review follows the (UK) National Institute for Health and Clinical Excellence 
(NICE) protocol for the development of its Public Health Guidance. This protocol 
highlights the importance of developing and applying transparent criteria for 
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inclusion and exclusion, data extraction, quality assessment, and data synthesis 
(NICE, 2012).  
Search strategy   
Grant (2004) warns that qualitative researchers may select different search terms 
and keywords from quantitative researchers, making such work more difficult to 
identify through database searches exclusively. Therefore, while database 
searches were the primary method used, the first author also undertook general 
Google searches, and checked through the reference lists of included studies.   
A comprehensive database search strategy was used to locate relevant 
qualitative literature across the following electronic sources: ASSIA (Applied 
Social Science Index and Abstracts), CINAHL (Cumulative Index of Nursing and 
Allied Health Literature) via EBSCO HOAT, MEDLINE via Ovid, PUBMED, Social 
Science Citation Index via Web of Science, and PsycINFO via EBSCO Host. 
These searches combined the following search terms relevant to the review 
questions: 
OAT: opioid, methadone, buprenorphine, drug or heroin in combination with 
use*, addict*, depend*.  
Prison: custod*, detention, jail, remand, correctional facilities, prison, inmate, 
detainee, punishment, imprison, incarcerat*.  
Qualitative studies: qualitative or mixed methods study/research, thematic 





The searches were limited to: primary research published between January 2005 
and December 2019. Search languages were restricted to English. 
Inclusion and exclusion criteria  
Types of participants  
Studies were included if they involved one or more of the following three 
stakeholder groups: policymakers (prison governors, government 
representatives), prison staff (doctors, physicians, nurses, psychiatrists, 
substance use counsellors, drug workers, prison officers) and prisoners. Studies 
that included only former  prisoners were excluded because the experience of 
current prisoners was thought to be more immediate or up-to-date. However, one 
study (Rhodes et al. 2019) with both current and former prisoners was included.  
Types of studies  
Studies were included if they involved any qualitative design elements, for 
example, ethnographic or interview-based studies. The qualitative elements of 
mixed-methods projects were included but studies that employed quantitative 
methods alone were not.  
Types of outcomes  
A range of outcomes was considered relevant, including the perspectives and 
experiences of policy-makers, prison officers, healthcare staff and prisoners on 
the implementation and delivery of OAT programmes in different countries with 
greater or lesser resources.  The latter was particularly important given the focus 
of the project to which this review contributed on an LMIC prison system (in a 
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predominantly Muslim country), Indonesia, in which the first author has 
experience of working.  
Selection process  
The data search generated 8091 papers. The records were saved as text files 
and imported into RefWorks. 4968 duplicate papers were removed. The 
remaining 3123 papers were reviewed based on title and abstract for inclusion 
by the researcher with a minimum of 10% of the literature double-screened by 
another author (SH). After screening 3086 papers were excluded. In total, 37 
papers were considered potentially relevant to the review, and full papers for 
these records were retrieved and read. Of these, 12 papers were identified as 
relevant to the review. A further four papers emerged through the additional 
searches described above. Overall, 16 papers met the selection criteria and were 
included in the review. A detailed overview of the selection process is shown in 










Figure 1. Search process used to identify papers within the review 
  
Quality assessment   
Literature that met the inclusion criteria was then assessed for quality and 
methodological rigour using the quality appraisal checklist for qualitative studies 
developed by NICE (2012). This checklist has been used extensively in public 
health research to assess the validity of qualitative studies. It consists of 15 
questions divided into seven sections: theoretical approach, study design, data 
collection, trustworthiness, analysis, ethics, and overall assessment. Two 
experienced qualitative researchers graded the studies for quality and 
disagreements were resolved by discussion.  
Articles selected  




Table 2. Papers included in the review of barriers and facilitators to the implementation of OAT programmes in prisons 




To describe the perceived benefits 
and challenges encountered by 
participants in the RIDOC’s 
medications for addiction treatment 
(MAT) program (methadone, 
buprenorphine, naltrexone  combined 
with behavioural therapy)  
40 prisoners: 28 male, 12 
female prisoners. These 
included  20 prisoners receiving 
methadone, 19 buprenorphine 
and 1, naltrexone.   
USA  Qualitative study. 





To examine compassion fatigue, 
burnout and job satisfaction of 
substance abuse counsellors. 
Ten counsellors (female and 
male) specialised in substance 
dependency treatment. 
USA Mixed methods.  
Interviews with participants about self-perceptions 
and their work as substance abuse counsellors.  
Thematic analysis. 
Awgu et al., 
2010. 
To increase knowledge of heroin-
dependent individuals and their 
satisfaction with and perceptions of 
methadone vs buprenorphine 
treatment. 




USA Mixed methods (unspecified) conducted during exit 
interviews with prisoners. 
The questionnaire collected primarily quantitative 
data but some open-ended questions were also 
included. These responses were coded 
thematically. 
Heimer et al.,  
2006. 
 
To describe and evaluate a pilot 
methadone maintenance programme 
for heroin-dependent inmates.  
To identify attitudes towards 
methadone and programme 
effectiveness.  
60 participants. 
Five government agencies 
created a cellblock and 
adjacent space for the 
provision of clinical, 
psychological, and social 
services for prisoners 




Mixed methods.  
Qualitative data: open-ended interviews with 
correctional officers focused on their beliefs about 
methadone, the usefulness of the current 





Reference  Aim(s) of the research  Participants   Country  Design  
Mjåland, 
2016. 
To explore prisoners’ and prison 
staff members’ perceptions on why 
drug use occurs in prison in the 
context of prison-based drug 
rehabilitation programs.  
21 male prisoners: 15 prisoners 
from drug rehabilitation unit and 
6 prisoners from the OMT unit. 
11 staff members: 6 prison 
officers, 2 drug counsellors, a 
psychologist, a social worker, a 
nurse. 
Norway  Qualitative  study. 
Semi-structured interviews and participant 
observation over 8 months of ethnographic fieldwork 
in two drug rehabilitation programs (a drug 




To explore the benefits of opioid 
maintenance treatment (OMT) in 
prison. 
23 prisoners and 12 staff 
members. 
Norway Qualitative study. 
Semi-structured interviews.  
Thematic analysis 





To examine practices/policies for 
the provision of substitution 
treatment.   
Baseline study of 15 EU 
countries involving ministerial 
representatives, professionals 
including service providers, 
security officials and prisoners. 
33 prisons across 17 countries 
with a total number of 184 
prisoners (132 male and 52 
female prisoners).   
EU  Qualitative study. 
33 Focus Group Discussions (FGDs).  
Content analysis. 
Page et al., 
2016. 
To explore the implications of the 
recovery agenda for opiate 
dependent prisoners in nine adult 
pilot Drug Recovery Wings ( DRW) 
prisons. DRWs emerged to 
encourage long-term heroin users 
receiving OAT to move towards 
abstinence. 
94 DRW staff and 102 DRW 
residents from 9 adult prisons.  
 
 
UK  Qualitative study. 
Semi-structured interviews. 






To explore the use of Subutex 
(buprenorphine) and its associated 
effects.  
14 male opioid-dependent drug 
users in seven Scottish prisons 
who had experience of illicit drug 




Interviews focused on prisoners’ subjective 
experiences of Subutex (buprenorphine) 





Reference  Aim(s) of the research  Participants   Country  Design  
Asher, 2013.  To evaluate the broader aims and 
potential consequences of maintaining 
remand and short-term prisoners on 
methadone. 
63 drug-using male prisoners 
(aged 22-53), and 11 drug 
workers in two local prisons in 




Qualitative study.  
In-depth semi-structured interviews.  
No information about the methods of data analysis.  
 
Carlin, 2005.  To explore staff and prisoner 
perceptions of prison methadone 
maintenance programmes. 
 
15 prisoners and 16 prison staff 
(management, nurses, medical 






Exploratory study.  
Purposive and snowball sampling. 31 semi-
structured interviews with prisoners and prison 
staff, 8 FGDs with prisoners.  
Thematic analysis. 
Larney et al., 
2017. 
To examine prisoners’ reasons for 
seeking OAT in custody, and intentions 
regarding continuation or cessation of 
treatment prior to and following release. 
46 prisoners from seven 
correctional centres: 32 male 











Moradi et al., 
2015. 
 
To assess the advantages and 
shortcomings of methadone 
programmes from the perspective of 
those involved in the delivery of prison 
healthcare. 
14 FGDs with a total of 140 
participants including 
physicians, consultants, 
experts, directors and 
managers of prisons from 
different prisons across Iran. 
Iran  Qualitative study. 
Purposive sampling. 14 FGDs with prison 
managers and physicians.  
Content and thematic framework analysis. 
  
Zamani et al., 
2010. 
To investigate the context in which 
methadone maintenance programme 
was provided for opioid-dependent 
prisoners, and to identify barriers to the 
further scaling-up of methadone 
programmes.   
30 male prisoners, 
15 staff including physicians, 
nurses, psychologists, prison 
managers and four health 
policymakers.  
 
Iran  This paper represents the qualitative phase of a 
longitudinal mixed-methods study. 
Purposive sampling, seven FGDs with prisoners, 











Reference  Aim(s) of the research  Participants   Country  Design  
Rhodes et 
al., 2019. 
To explore the implementation of an 
internationally-supported programme of 
methadone treatment. 
22 male prisoners with histories 
of injecting drug use and 21 
prison staff members in three 
prisons in Bishkek between 
2016 and 2018. 
Kyrgyzstan A qualitative case study. 
Semi-structured interviews and observation. 
22 interviews before and 20 interviews after 
release from prison. 
Constructivist grounded analysis.  
Culbert et 
al., 2015.   
 
To examine the prevalence, correlation, 
and social context of injecting drug use 
among HIV-infected male prisoners in 
Indonesia.  
102 HIV-infected male 
prisoners aged ≥ 18 years from 
one narcotics and one non-




Semi structured interviews on the socio-
environmental context of injection drug use.  






Characteristics of the studies included in the review 
Four studies employed mixed-methods (Culbert et al., 2015, Perkins and Sprang, 
2013, Awgu et al., 2010, Heimer at al., 2006). All the studies conducted either semi-
structured or open-ended interviews, focus groups or observation to collect data. Six 
studies assessed methadone and/or buprenorphine detoxification and/or maintenance 
programmes (Larney et al., 2017, Rubinstein et al., 2017, Perkins and Sprang, 2013, 
Johnstone et al., 2011, Stöver et al., 2006, Asher, 2013), while the remaining studies 
reviewed methadone maintenance programmes alone. Only four studies were 
conducted in LMIC countries (Kyrgyzstan, Indonesia and  Iran) (Rhodes et al., 2019, 
Culbert et al., 2015, Moradi et al., 2015, Zamani et al., 2010). 
Method of qualitative synthesis  
Following NICE guidelines, coding of the selected articles began with a review of each 
line and paragraph of the articles identified, guided by the review questions. The codes 
identified through this process were entered into an Excel spreadsheet to generate an 
initial list of codes. The similarities and differences between the codes were compared 
and themes found to be related conceptually were grouped into categories. Three 
central themes emerged from this process: 
1. Perceived benefits of OAT programmes  
2. Barriers to the implementation and development of OAT programmes 
3. Treatment processes. 
Within each theme, barriers to, and facilitators of, the implementation and delivery of, 





Perceived benefits of OAT programmes 
In general, all stakeholders considered OAT programmes to be beneficial to prisoners, 
to prisoners’ families and to prison systems. Benefits identified by prisoners included 
reduction in the sharing of injecting equipment, thus reducing the risk of BBV 
infections; improvements in health (Larney et al., 2017, Zamani et al., 2010, Carlin, 
2005); the alleviation of craving and heroin withdrawal symptoms (Larney et al., 2017, 
Brinkley-Rubinstein  et al., 2017, Moradi et al., 2015, Awgu et al., 2010, Stöver et al., 
2006, Carlin, 2005), and  improvements in prisoners’ financial situation and social lives 
while incarcerated (Moradi et al., 2015, Carlin, 2005). One US prisoner drew on 
religious language to communicate the sense of relief that participation in the 
programme had afforded them:  
“I don’t have to worry about getting something off somebody and doing 
that whole criminal activity or owing people anything. I do my own 
program in here, and I’m good. I don’t need anything else. It’s a blessing” 
(Brinkley-Rubinstein et al., 2017, p. 3). 
Benefits for families included a reduction in prisoners’ need for financial support 
(Larney et al., 2017, Asher, 2013, Zamani et al., 2010, Carlin, 2005), especially in 
LMIC contexts where families must provide food, participation in prison services is not 
always free and the extremely low staff pay meant that prisoners often needed to pay 
bribes. Prisoners’ participation in methadone programmes similarly reduced their 




greater sense of assurance about their relatives’ safety while in prison (Zamani et al., 
2010).  
Several studies similarly found that the availability and consumption of illicit drugs in 
prisons reduced, and that consequently, prisoners were less tense, easier to manage 
and that there were fewer drug-related crimes committed in these prisons (Brinkley-
Rubinstein  et al., 2017, Moradi et al., 2015, Asher, 2013, Zamani et al., 2010, Carlin, 
2005). Feelings of greater security linked to the implementation of prison OAT 
programmes were also expressed by an Iranian staff member: 
“There has been an obvious reduction in escape, riot, tension, conflict 
and self-injury among the prisoners, especially addicts, after the 
introduction of the MMT” (Moradi et al., 2015, p. 585). 
Relatedly, prison systems also benefited through improved staff morale. For example, 
the reduction in the dangers posed to staff members by injecting equipment, and the 
higher rates of treatment among prisoners receiving OAT programmes, were 
associated in some contexts with feelings of greater security at work and pride at 
having changed something for the better. An Iranian prison officer illustrates these 
points, highlighting the proportion of prisoners treated:  
“Implementation of this program has meant that we do not see injecting 
tools to the same extent anymore; I cannot say there are not any at all, 
but their use has been reduced significantly, [and] we have treated over 





OAT programmes have also been associated with the increased uptake of other prison 
services (Stöver et al., 2006), including counselling, education sessions, and sports 
(Moradi et al., 2015).  
Barriers to the delivery and development of AT programmes 
While studies have demonstrated benefits for prisoners, their families and prison staff, 
significant barriers to the delivery of, and prisoner participation in these programmes 
have also been identified (Grella et al. 2020). This review identified similar barriers 
including the availability of illicit drugs, low levels of understanding about the OAT 
programmes among both staff and prisoners, concerns about withdrawal, and the 
stigma associated with participating in methadone programmes.  
Availability of illicit drugs  
In many places, the easy availability of illicit drugs in prisons made it difficult for 
prisoners to remain abstinent from illicit drugs during treatment (Mjåland, 2016, Page 
et al., 2016, Culbert et al., 2015, Asher, 2013). Indeed, low prison staff pay, particularly 
in LMIC countries, meant that working in prisons was often a secondary not a primary 
job, and prison officers were suspected of bringing drugs into prisons to sell in order 
to supplement their low pay (Moradi et al., 2015). 
Furthermore, other prisoners encouraged those on OAT programmes to continue 
using illicit drugs. As a result, prisoners progressed from inhalation to injection in 
prisons to deal with their consequent increased tolerance for heroin (i.e. the need for 
a larger quantity of drug to achieve the same subjective effects) (Asher, 2013, 




Lack of understanding of harm reduction  
A recurrent barrier to the efficient delivery of prison OAT programmes was the lack of 
understanding among all prison stakeholders of the purposes of OAT programmes 
and their role in reducing the harms associated with the injection of illicit opiates.  
Prisoners and prison officers often understood the function of OAT programmes in 
relation to the alleviation of heroin withdrawal symptoms, but rarely in terms of the 
reduction of associated harms (Stöver et al., 2006, Carlin, 2005). As Moradi et al. 
found: 
“Objectives are unknown for inmates and officials; there are great 
expectations about the therapeutic effects of methadone treatment 
programs, while these expectations are not among the [programmes] 
main objectives” (2015, p.587). 
Strikingly, objectives relating to harm reduction –namely the reduction of blood-borne 
diseases such as HIV and hepatitis B and C infection associated with sharing used 
equipment - were recognised in only one study (Larney et al., 2017). 
Such gaps in understanding were sometimes reinforced, and the effectiveness of the 
programmes in harm reduction terms distorted, by the means adopted by prison 
authorities to measure or audit success. Notably, where uptake rates were used as 
indicators of success, healthcare workers felt pressured to include non-opioid injecting 
drug users in their programmes (Moradi et al. 2015, Stöver et al., 2006), while 
successful programmes were sometimes assessed as failing because of low 




Prison staff also used the programmes for their own purposes. Several studies 
highlighted that prison staff and prisoners associated the introduction of OAT 
programmes with the control and regulation of prisoners’ behaviour (Carlin, 2005). 
Methadone was used either as a reward (Stöver et al., 2006), or punishment (Moradi 
et al., 2015) in such instances. Prisons were described as highly tense environments, 
in which prison officers were under great pressure and would use whatever means 
were at their disposal to maintain order. As one prison officer in the Republic of Ireland 
put it:  
“My understanding is that methadone keeps a lid on the prison. It 
stabilized prisoners who are taking drugs. Methadone helps them to 
mellow out” (Carlin, 2005, p.413). 
The lack of understanding of the effects and function of methadone  
Studies in the US, UK, EU, Iran, Kyrgyzstan and Indonesia all found that concerns 
relating to the perceived side-effects of methadone deterred participation. Both 
prisoners and their families viewed methadone withdrawal as worse than heroin 
withdrawal, and even as lethal (Rhodes et al., 2019, Johnstone et al., 2011, Zamani 
et al., 2010, Stöver et al., 2006, Carlin, 2005). Qualitative data made the strength of 
these fears clear:  
“A person beings to transform from a human into an animal. They have 
ulcers, all of them. All of them are rotting, and such a smell. It’s [the 
methadone treatment programme] like a monkey house. People are 






“Methadone will stop the craving, but will kill you quicker. It is better just 
to take heroin” (Culbert et al., 2015, p. 75; a prisoner  in Indonesia). 
Another recurrent misconception was that methadone programmes simply substituted 
one drug dependence for another (Asher, 2013, Stöver et al., 2006, Carlin, 2005):  
“I came in [to prison] on methadone...and I came off because basically I 
did not want to be on it anymore; I thought it was basically replacing one 
addiction with another” (Larney et al., 2017, p.307; a prisoner in NSW). 
Some of the comments reported around methadone did not reflect a straightforward 
rejection of OAT programmes, but rather a preference for the use of buprenorphine 
over methadone by staff and prisoners (Asher, 2013). Prisoners often reported more 
positive experiences in reducing withdrawal and craving from opioids with these drugs 
(Larney et al., 2017, Johnstone et al., 2011, Awgu et al., 2010) but their availability is 
limited in prisons (Larney et al., 2017, Brinkley-Rubinstein et al., 2017, Johnstone et 
al., 2011, Awgu et al., 2010). 
Fear of stigmatisation  
Fear of stigmatisation also affected OAT participation and ultimately limited the 
expansion of such programmes (Culbert et al., 2015). Notably, Stöver et al., (2006) 
found that on admission to prisons across the EU many prisoners avoided accessing 
medical treatment for this reason. The lack of confidentiality in dispensing methadone 
also undermined some prisoners’ self-image (Carlin, 2005). These problems were 




to OAT programme participants by other prisoners and prison staff at all levels. OAP 
participation was linked to homosexuality, poverty, being of lower class, being a traitor, 
and having AIDS (Rhodes et al., 2019, Culbert et al., 2015, Moradi et al., 2015, Zamani 
et al., 2010):  
“Those who are not taking methadone think that those who are receiving 
methadone either have AIDS or, I apologize for saying this, have became 
lasshi [an offensive term for a homosexual man] and cannot afford to buy 
drugs” (Zamani et al., 2010, p. 170; Iran). 
In contrast, a few studies found that prison staff held less stigmatising attitudes 
towards prisoners receiving methadone as compared to heroin users when they had 
a better understanding of prisoners’ backgrounds (Moradi et al., 2015, Johnstone et 
al., 2011, Carlin, 2005). Sometimes such understandings drew upon a family history 
of addiction (Perkins and Sprang, 2013).  
Systemic problems affecting the delivery of, and participation in, prison OAT 
programmes  
Prison systems and structures can also affect the delivery of OAT programmes, 
through the provision of insufficient resources to support them and by restricting the 
time-frame in which participation is possible.  
In many places studied, there were no supportive prison policies or guidelines, and 
where they did exist, implementation varied (Stöver et al., 2006). Furthermore, the 
duration of OAT programmes was often very limited as a result of being linked closely 




these times or was strictly time-limited to periods of between six and twelve months 
(Stöver et al., 2006).  
A lack of treatment continuity when prisoners were transferred to prisons without OAT 
programmes was another common problem. In many contexts, the continuity of 
treatment between prisons was low when compared to between community-based 
services (Stöver et al., 2006, Carlin, 2005). Prisoners often faced problems on release 
as a result of inadequate prison-community services referral systems (Zamani et al., 
2010). In such circumstances, they needed to draw on family help or try to make their 
own referrals, as explained by a US prisoner.   
“if they [family] can’t do it for you, like you have to have a way to do it 
yourself” (Brinkley-Rubinstein  et al., 2017, p.5). 
In response to such inadequate referral systems across the EU, Stöver et al. (2006) 
suggested conducting regular meetings among prison staff, and greater collaboration 
between institutional prisons and the community OAT programmes services. 
A lack of funding and resources is widespread and a considerable barrier to continuing 
and to scaling-up OAT programmes in prisons since it often led to a lack of staff, of 
staff training and of equipment and space. This reinforced prisoners’ concerns about 
privacy and confidentiality mentioned above (Heimer et al., 2006b). Psychosocial 
services were frequently unavailable or not fully integrated into prison OAT 
programmes (Zamani et al., 2010, Heimer et al., 2006b). This situation has persisted 
despite the recognition that such services -involving psychologists, pedagogues, 
educators, and social workers- can be critical to maintaining lower methadone doses 




(Stöver et al., 2006 Brinkley-Rubinstein  et al., 2017, Johnstone et al. 2011). Staff 
shortages were also associated with increased work pressure (Carlin, 2005), longer 
waiting lists (Zamani et al., 2010) and higher rates of methadone diversion due to a 
lack of supervision (Moradi et al., 2015, Zamani et al., 2010).  
These problems were particularly acute in LMIC where prisoner to prison staff ratios 
are much higher. As Moradi et al. explain: “[s]hortage of budget, staff, equipment and 
facilities […]. These deficiencies sometimes cause the programs to be stopped” (2015, 
p.587). Several studies also noted a lack of community-based services. In Iran, most 
community programmes were concentrated in urban centres. As such, many ex-
prisoners from rural areas registered for urban OAT programmes leading to long 
waiting lists (Zamani et al., 2010). As noted, this lack of resources also increased the 
burden on families who were expected to provide greater financial support.  
Treatment procedures and practices 
Treatment procedures and practices and a lack of space in prison also affected access 
to and participation in prison OAT programmes, particularly in LMIC countries.  
Admission criteria 
In some non-“western” countries, the requirement for family consent presented a 
significant barrier to prisoner participation. Many prisoners found it difficult to obtain 
such consent since some had been rejected by their families, while other families knew 
nothing of their drug use (Culbert et al., 2015). In such contexts, the use of uptake 
rates as an indicator of success, as discussed above, is particularly problematic 





Rigid dispensing practices and lack of confidentiality were problematic in many places. 
In one study the process of dispensing drugs was described as “chaotic”. The use of 
de-humanising imagery was also common in describing these processes. Prison staff 
described prisoners as "lions around the carcass of a dead animal", while prisoners 
felt they were shepherded around like "cows or sheep" (Carlin 2005, p.412). Often 
prisoners were required to attend a daily methadone clinic (Johnstone et al., 2011, 
Awgu et al., 2010) leading to a lack of privacy, since prison staff and other prisoners 
were able to identify those attending as drug users (Mjåland et al., 2015, Awgu et al., 
2010, Carlin, 2005). Their comparison of practices across the EU led Stöver et al. 
(2006) to recommend that methadone either be dispensed alongside other medication 
or that prisoners receiving methadone should be allocated to one unit to better protect 
their confidentiality and, therefore, reduce their exposure to stigma.  
Prison staff often defended such non-confidential practices as necessary to combat 
high rates of non-adherence and diversion, the latter being used by prisoners to obtain 
money or relief from bullying (Larney et al., 2017). Such diversion was possible where 
there was a lack of healthcare staff supervision and prisoners received higher doses 
than they felt they needed (Mjåland et al., 2015, Zamani et al., 2010). In higher income 
countries, diversion often reflected profit-related motivations whereas in LMIC 
countries, this practice also reflected prisoners’ substantial need for money while in 
prison, as discussed above. However, although many prisoners in the two Iranian 
studies (Moradi et al., 2015, Zamani et al., 2010) reported diversion issues, these 
aspects were often unrecognised by policy makers when they planned to scale–up 





Very few reviews have conducted an in-depth analysis of qualitative evidence to 
explore the diverse perspectives and experiences of the wide range of stakeholders 
involved in OAT programmes (policymakers, prison officers, healthcare staff and 
prisoners), or to identify elements of prison contexts and OAT programmes that act as 
barriers to, or motivating factors for the implementation and maintenance of, and 
prisoner participation in such programmes. As a result, the importance of context, and 
of stakeholder understandings of the policies around, and reasons for, implementing 
of OAT programmes has been vastly underestimated. 
Although the cultural, resource and policy contexts of the studies reviewed differed 
greatly, constraints on delivery were reported across all countries where qualitative 
data have been collected on the implementation and delivery of OAT programmes in 
prisons. This finding is consistent with those of Grella et al. (2020). Common systemic 
issues included disruption resulting from the limited length of treatment periods and 
problems relating to prisoner transfer and post-release support. The research 
conducted in the UK, EU, and US highlighted problems relating to transfer between 
prisons because of the low coverage of OAT programmes across prisons compared 
to those in the community. In LMIC countries, a lack of treatment in community settings 
alongside a lack of referral systems amplified these problems greatly.  
Studies in countries such as the US and the UK, were less likely to report barriers to 
resources in prisons when compared to those conducted in LMICs, suggesting that 
the programmes have received greater and more consistent support in high-income 
countries. Many prisoners have emphasised a need for psychosocial support in prison 




Medication-Assisted Treatment (MAT) programmes (OAT programmes combined with 
behavioural therapy) to help overcome drug use problems and improve physical, and 
psychosocial health conditions (Jhanjee, 2014). However, research in LMIC prison 
systems reported much higher prisoner-staff ratios and much less funding for such 
complementary services. As such, and combined with the lack of other harm reduction 
strategies such as needle, syringe and bleach distribution programmes, these studies 
reaffirmed prisons as high risk environments (Rhodes, 2002) for HIV transmission 
particularly in LMIC settings.  
Overall, there was a clear lack of understanding of the role of OAT programmes as 
part of harm reduction programmes. Often these misunderstandings seemed to reflect 
notions of prisons as exclusively places of punishment rather than rehabilitation. 
Indeed, in one of the LMIC settings (Iran), these misunderstandings were also 
associated with punitive practices by prison staff (Moradi et al., 2015). Furthermore, 
many prisoners doubted that OAT programmes could help them. They feared the side 
effects of methadone and associated withdrawal symptoms more than those of illicit 
heroin. As a result, the authors of some studies recommended providing alternative 
treatment options such as non-injectable buprenorphine to overcome these concerns.  
Stigmatising attitudes towards prisoners’ participation in OAT programmes were also 
reported by all stakeholders in both high income-and LMIC countries. As indicated in 
a previous study (Gordis, 1991), these attitudes discouraged prisoner participation and 
prevented programmes from being scaled-up. In some higher income countries, 
vulnerability to stigmatisation has been reduced and participation improved by 
providing greater privacy during the dispensing of drugs. In the LMIC countries 




programmes since family consent to treatment is often required, but often denied or 
never requested due to this stigma. 
Strengths and Limitations 
The strength of this review lies in its focus on qualitative data, which has revealed 
important barriers to the implementation of, and participation in, OAT programmes in 
prison. It also provides valuable insights into some of the determinants of the 
successful delivery of the OAT programmes in different contexts. This approach 
provides a much more holistic and comprehensive view to inform the development of 
OAT policies and practices than is possible from focusing on quantitative reviews 
alone. 
Concerning the search strategies employed, it is possible that some relevant studies 
were missed. The researcher mitigated this possibility, at least in terms of papers 
published in English, by searching for relevant reference lists from the included 
studies. Although mixed methods papers were included, the researcher found only a 
small number of qualitative studies which met the inclusion criteria for the review. As 
Grella et al. (2020) also found, this observation indicates a significant lack of qualitative 
studies on OAT programmes in prisons. Other limitations were that only papers 
published from countries where OAT is available in prison were included in the review 
and that studies of former prisoners were excluded. On reflection, including studies of 
former prisoners might have provided a broader perspective, as it is likely that they 







This systematic review of qualitative studies provides an in-depth understanding of the 
barriers to, and facilitators of, delivery and participation in prison OAT programmes in 
diverse contexts and from the perspectives of a range of stakeholders. The review 
highlights the importance of drawing on interpretivist approaches and suggests that 
the resulting contextualised and nuanced understandings of the benefits of OAT 
programmes are crucial to improving prison systems and prisoner participation. 
A lack of a clear understanding of their role as part of harm reduction and OUD 
treatment programmes, as well as doubts relating to the substances they employ, are 
critical barriers to OAT programmes in both higher-income and lower/middle income 
countries. In addition, prison system organisation and (lack of) structures may disrupt 
programmes within prisons, prisoner transfer between prisons and post-release care. 
At the same time, it is difficult for stakeholders and healthcare staff effectively to 
mitigate poor implementation of the OAT programmes in prisons given a lack of 
resources, particularly in LMIC. The family-centred approach to healthcare services in 
prisons in some LMIC, and stigmatisation of OAT programmes in all settings have 
fostered feelings of vulnerability among prisoners and further deter participation.  
Stakeholders both in high- and LMIC should focus on strengthening the facilitators and 
mitigating the barriers to improved implementation and to scaling-up the programmes. 
This review also indicates the need to develop open discussion between all 
stakeholders (prison managers, healthcare staff, prison officers and prisoners) to 
determine how best to coordinate programme implementation. It is clear that some of 




methadone (where used) and harm reduction that engages with local understandings 
and is cognisant of the ways such understandings are reinforced. 
This paper further indicates there is  an urgent need to develop more qualitative work, 
incorporating varied methods, on delivering prison OAT programmes. Such work 
should take diverse contexts including of limited resources, and the organisation of 
health care around family rather then the individual into account, to minimize the 
impact of harms related to OUDs in prisons. The importance of undertaking systematic 
reviews that take into full account the value of qualitative data in providing a more in-
depth and broader understanding of these issues, of the diverse meanings of 
methadone and of the materialities of its provision is also highlighted. Notably, the 
quotations included in this review provide powerful illustrations of stakeholders’ 
circumstances. Furthermore, the different significance of money for prisoners and staff 
within higher and LMIC prisons, and of culturally-inflected organisation of health care 
is perhaps more easily understood through such quotations. Such nuances are more 
likely to be lost in the necessarily more general terms used in quantitative work or, 
indeed, where interpretation of qualitative data is undertaken by culturally-
homogenous research teams.  
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